A preliminary study of platelet hyperactivity in the chronic indeterminate phase of Chagas' disease.

The chronic indeterminate phase of Chagas' disease is asymptomatic despite positive test results for antibodies specific to Trypanosoma cruzi. CD62P-APC (P-selectin) and PAC-1 FITC (GpIIb/IIIa) may improve diagnosis as biomarkers of platelet activity. Nine asymptomatic seropositive subjects, previously untreated, were selected from a blood bank within a year of Chagas' disease detection, in addition to a control group of four.

[Seroprevalence of Trypanosoma cruzi antibodies and associated risk factors among the population under 18 years of age in Veracruz, Mexico].

Objectives: To determine the prevalence of Trypanasoma cruzi antibodies among the population under 18 years of age in the state of Veracruz, Mexico, and to identify risk factors associated with housing conditions and vector presence and distribution.

Methods: A cross-sectional, epidemiological study of the population under 18 years of age living in 10 of the 11 health districts of the state of Veracruz, Mexico, from 2000 to 2001. Presence of T.